Business Description
Catalent Inc
NAICS : 325412
SIC : 2834
ISIN : US1488061029
Compare
Compare
Traded in other countries / regions
CTLT.USA0C8.GermanyCTLT.Mexico IPO Date
2014-07-31Description
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 1.27 | |||||
| Debt-to-EBITDA | -7.02 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.95 | |||||
| Beneish M-Score | -2.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.1 | |||||
| 3-Year FCF Growth Rate | -118.3 | |||||
| 3-Year Book Growth Rate | 13 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 18.44 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.07 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.86 | |||||
| 9-Day RSI | 51.74 | |||||
| 14-Day RSI | 49.43 | |||||
| 6-1 Month Momentum % | -7.63 | |||||
| 12-1 Month Momentum % | -31.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.71 | |||||
| Quick Ratio | 1.19 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 88.35 | |||||
| Days Sales Outstanding | 81.98 | |||||
| Days Payable | 43.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.5 | |||||
| Shareholder Yield % | -8.08 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.21 | |||||
| Operating Margin % | -0.52 | |||||
| Net Margin % | -22.36 | |||||
| FCF Margin % | -5.55 | |||||
| ROE % | -20.72 | |||||
| ROA % | -8.93 | |||||
| ROIC % | -0.19 | |||||
| ROC (Joel Greenblatt) % | -19.07 | |||||
| ROCE % | -9.93 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 47.62 | |||||
| Shiller PE Ratio | 42.37 | |||||
| PS Ratio | 1.74 | |||||
| PB Ratio | 1.82 | |||||
| Price-to-Tangible-Book | 1.82 | |||||
| Price-to-Operating-Cash-Flow | 26.02 | |||||
| EV-to-EBIT | -12.92 | |||||
| EV-to-Forward-EBIT | -449.69 | |||||
| EV-to-EBITDA | -16.76 | |||||
| EV-to-Forward-EBITDA | 32.52 | |||||
| EV-to-Revenue | 2.79 | |||||
| EV-to-Forward-Revenue | 2.66 | |||||
| EV-to-FCF | -50.51 | |||||
| Price-to-Projected-FCF | 3.77 | |||||
| Earnings Yield (Greenblatt) % | -7.74 | |||||
| FCF Yield % | -3.31 | |||||
| Forward Rate of Return (Yacktman) % | 0.96 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CTLT
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Catalent Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,236 | ||
| EPS (TTM) ($) | -5.24 | ||
| Beta | 0.99 | ||
| Volatility % | 63.68 | ||
| 14-Day RSI | 49.43 | ||
| 14-Day ATR ($) | 1.572037 | ||
| 20-Day SMA ($) | 37.136 | ||
| 12-1 Month Momentum % | -31.4 | ||
| 52-Week Range ($) | 31.45 - 74.49 | ||
| Shares Outstanding (Mil) | 180.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Catalent Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Catalent Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Catalent Inc Frequently Asked Questions
What is Catalent Inc(CTLT)'s stock price today?
The current price of CTLT is $39.40. The 52 week high of CTLT is $74.49 and 52 week low is $31.45.
When is next earnings date of Catalent Inc(CTLT)?
The next earnings date of Catalent Inc(CTLT) is 2024-02-07 Est..
Does Catalent Inc(CTLT) pay dividends? If so, how much?
Catalent Inc(CTLT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers